Highlights

  • Latest verified development: fiscal 2026 results
  • Aeluma, Inc. (Nasdaq: ALMU), a semiconductor technology company whose management describes a shift from early-stage government research contracts toward commercial AI data-centre photonics.
  • Full-year revenue was $4.46 million against $4.67 million in fiscal 2025, a decline of about 5%, within the $4.2 million to $4.6 million range the company had set in May.
  • The fourth-quarter net loss was $4.01 million, or $0.22 per share, compared with $1.8 million in the third quarter; the non-GAAP net loss was $2.71 million.

Latest verified development: fiscal 2026 results

Aeluma, Inc. (Nasdaq: ALMU), a semiconductor technology company whose management describes a shift from early-stage government research contracts toward commercial AI data-centre photonics, announced fiscal 2026 fourth-quarter and full-year results in mid-September 2026; a company notice scheduled the call for 16 September. The summary below relies on a secondary report dated 18 September, supplemented by the company's May 2026 release, because The reviewed material did not retrieve the full September release.

Fourth-quarter revenue was $582,000, down from $1.22 million in the third quarter and $1.32 million a year earlier, a sequential fall of about 52% on my arithmetic. Full-year revenue was $4.46 million against $4.67 million in fiscal 2025, a decline of about 5%, within the $4.2 million to $4.6 million range the company had set in May.

Losses and cash

The fourth-quarter net loss was $4.01 million, or $0.22 per share, compared with $1.8 million in the third quarter; the non-GAAP net loss was $2.71 million. The full-year net loss rose to $9.16 million from $3.02 million. The prior-year loss was reduced by a one-time $2.3 million gain on derivative liabilities recorded in the quarter ended March 2025, according to the May release, which flatters that comparison.

Cash stood at $56 million at year-end, up from $37.8 million at 31 March 2026, helped by $20.1 million of net proceeds from an at-the-market share offering. Funding growth through share sales increases the share count, which dilutes existing holders, so that financing is a relevant feature of the cash figure. Adding the offering proceeds to the March balance gives $57.9 million, against $56 million reported, which implies a net outflow of roughly $2 million in the quarter, my own approximation that ignores other cash movements.

Contracts, funding and commercial progress

The company reported six new contracts totalling $5.3 million, including awards connected with NASA and the U.S. Navy. It also said discussions with prospective AI datacom customers have advanced to negotiations for multimillion-dollar non-recurring engineering agreements. Negotiations are not signed contracts, and no amounts or counterparties were disclosed in the material I reviewed.

Separately, the company referred to potential funding of up to $30 million from the U.S. Department of Commerce CHIPS R&D Office, subject to a definitive agreement. Until that agreement is signed, the amount remains a possibility rather than committed capital.

Management outlook

Chief executive Jonathan Klamkin said the company is transitioning from early-stage government research contracts to a focus on scale and commercialisation, and that fiscal 2027 will focus on technology and product development and on expanding customer engagements. No numeric guidance for fiscal 2027 was reported in the source I reviewed.

In May, Klamkin had said the AI data-centre buildout was outpacing the scale of the photonics supply chain. That is a management view about market conditions, not a reported result.

Share Price and the Next Test

StockAnalysis.com recorded ALMU closing at $9.12 on 14 October 2026, down from $9.81 on 13 October and $10.42 on 12 October. Google Finance showed $13.29 at the 25 September close, so the shares were about 31% lower on 14 October by my arithmetic. The reviewed material did not identify a company announcement explaining the decline and attribute it to no cause.

The reviewed material did not verify Aeluma as a constituent of a named index from an authoritative source, so the Nasdaq Composite is used only as a labelled benchmark. Nothing here implies index membership.

Items to watch include whether the datacom negotiations convert into signed agreements, whether the CHIPS funding is finalised, and how quarterly revenue and cash use evolve from the lower fourth-quarter base. Readers should treat all of fiscal 2026 figures here as provisional until checked against the full company release and annual report on Form 10-K, once filed.